Stylus Medicine

📍 Cambridge, United States👥 45 employees💰 Last funded 2024
Biotechnology Research🌐 stylusmedicine.com
Website LinkedIn
Stylus Medicine is developing transformative in vivo genetic medicines to unlock cures. Stylus combines engineered recombinases with non-viral delivery to specifically encode therapeutics. The company’s approach is versatile and modular, with potential therapeutic application across oncology, autoimmune, genetic diseases, and beyond.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Stylus Medicine?
Stylus Medicine has 1 investors on record on gritt.io.
When did Stylus Medicine last raise funding?
The most recent investment in Stylus Medicine recorded on gritt.io was in 2024.
What industry is Stylus Medicine in?
Stylus Medicine operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Stylus Medicine based?
Stylus Medicine is headquartered in Cambridge, United States.